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Cord blood bilirubin analysis helps not only in predicting the pathological jaundice in ABO incompatibility but is also useful for early referral and intervention for better 
outcome. Jaundice is the most common condition that requires 
medical attention and neonatal intensive care unit (NICU) 
admission in newborns [1]. ABO incompatibility is an important 
cause for pathological jaundice. Jaundice, due to any other cause, 
is more likely to be more severe in ABO incompatible babies than 
compatible ones; about 70% of the term and most of the preterm 
neonates develop hyperbilirubinemia. Furthermore, 6.1% of well 
term newborn have a maximum serum bilirubin level >12.9 mg/dl. 
A serum bilirubin >15 mg/dl is seen in 3% of normal full-term 
neonates [2]. As early discharges have become a common practice 
nowadays in many centers, babies are commonly readmitted after 
3 days for the management of jaundice [3]. Screening the cord 
blood bilirubin levels can be used as a significant modality in 
identifying babies with ABO setting even in resource-limited 
center so that they can be referred early and appropriate treatment 
can be initiated to prevent complications like bilirubin-induced 
neurological damage (BIND).
ABO incompatibility occurs in about 20–25% of pregnancies, 
but severe hemolytic disease develops in only one in 10 of such 
offspring. The exact level of serum bilirubin that can cause brain 
damage in term and otherwise healthy infant is not predictable. 
The aim of the study was to evaluate the cord blood bilirubin in 
predicting pathological hyperbilirubinemia in a term newborn at 
risk of ABO incompatibility.
MATERIALS AND METHODS
This was a cohort study conducted at the Department of Paediatrics 
and Neonatology, at a Medical College of South India from 
February 2018 to July 2018. This study was initiated after getting 
approval from the institutional ethics committee. A detailed history 
was taken and cord blood was collected for all the babies born 
to O positive group mother. On the 4th day, serum bilirubin was 
collected for those babies with A, B, or AB blood groups. A total 
of 70 term newborn babies were included in this study.
Inclusion criteria were as follows: Babies with A, B, or AB 
blood groups born to O positive mothers, with gestational age 
of more than 37 weeks, birth weight of more than 2.5 kg, and 
APGAR score of >7 at 1 min of life while the sick newborns 
admitted in NICU, those who have APGAR score <7 at 1 min, 
preterm babies <37 weeks, and newborns <2500 g, babies born 
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to mothers with medical disease such as eclampsia, diabetes, and 
thyroid and babies with cephalhematoma were excluded from the 
study.
Written consent was taken regarding the participation of the 
mother and baby in the study. History of jaundice in previous 
sibling, if any, was noted. Samples were taken for testing blood 
grouping, Rh typing, and cord blood hemoglobin, direct Coombs 
test, and serum bilirubin. Serum bilirubin was estimated by 
DIAZO method and its value was collected on the 4th day of 
life (>72 h of life). If bilirubin was more than 15 mg/dl or if the 
bilirubin levels fall in therapeutic range as per the AAP guidelines 
for phototherapy for infants of 35 or more weeks of gestation [4], 
hyperbilirubinemia was taken as pathological.
RESULTS
Of 70 babies who were at risk of ABO incompatibility, 41 (59%) 
babies were male and 29 (41%) were female. Among the study 
subjects, 27 (38.5%) belonged to A positive blood group, 
39 (55.7%) to B positive, 3 (4.29%) subjects were B negative, 
and 1 (1.23%) subject was of A negative blood group. None of 
the baby had AB positive or AB negative blood groups. Of 70 
babies, 25 (35.7%) developed pathological jaundice requiring 
phototherapy and 45 (64.3%) were in physiological range who did 
not receive any treatment. One baby needed exchange transfusion 
among 25 babies with pathological jaundice. No babies in the 
study group developed BIND or kernicterus.
In physiological jaundice group, the mean value of 
bilirubin on the 4th day of life was 11.05 mg/dl (range - 5.4–
14.7 mg/dl), and in pathological jaundice group, it was 16.3 mg/dl 
(range - 15–21.7 mg/dl). Receiver operating characteristic (ROC) 
curve of cord blood bilirubin in babies with ABO setting (Fig. 1) 
showed the cord blood bilirubin value of 2.25 mg/dl. It was found 
to be a good predictor for pathological jaundice, with an area 
under the curve of 0.775 and a sensitivity of 84.0% and specificity 
of 71.1%.
The ROC curve of major blood Groups A and B (Fig. 2) 
showed that the cord blood bilirubin value of 2.25 was found 
to be a good predictor for pathological jaundice. Among A 
positive blood group babies, the cord blood bilirubin value cutoff 
of 2.25 mg/dl showed an area under the curve of 0.739 and a 
sensitivity of 72.7% and specificity of 81.2%. Similarly, among 
B positive blood group babies, the cord blood bilirubin value 
cutoff of 2.25 mg/dl showed good predictability with area under 
the curve of 0.837, sensitivity of 92.9%, and specificity of 68%. 
Hence, cord bilirubin level of 2.25 mg% seems to be the best 
cutoff value for identifying pathological jaundice in our study 
subjects.
DISCUSSION
Jaundice is the most common condition that requires medical 
attention in newborns [5]. The problem is that the prediction 
of jaundice becomes more difficult, especially when babies are 
discharged early. Neonatal pathological hyperbilirubinemia is 
a frequent cause of readmission of newborns due to the recent 
trends of early discharge from hospital.
This study was done to identify the best cutoff value of cord 
blood bilirubin in predicting the occurrence of pathological 
hyperbilirubinemia, in babies with ABO setting. It will help such 
babies to be referred to early and appropriate treatment, which 
can be initiated even in resource-limited centers. This study 
showed that newborn with cord blood bilirubin >2.25 mg/dl 
is prone for pathological hyperbilirubinemia with a sensitivity 
of 84% and specificity of 71.1%. Rataj et al. [6] showed that 
critical level in cord blood >2.5 mg/dl had probability of 
89% for the development of significant hyperbilirubinemia in 
newborns.
AlaaEldin et al. [7] study showed, if cutoff value of cord blood 
bilirubin is kept as 2.15 mg%, it gives a sensitivity of 50% and 
specificity of 97% in predicting pathological hyperbilirubinemia. 
Taksande et al. [8] found that the cord serum bilirubin values 
>2 mg/dl have a sensitivity of 89.5% and specificity of 85% 
in predicting pathological hyperbilirubinemia. In a study by 
Rostami and Mehrabi [9], the cutoff point of 2 mg/dl had the 
sensitivity of 59.2% and the specificity of 48.1%. Krishnan 
et al. [10] study showed that cord bilirubin value of >1.8 has 
a sensitivity of 72% and specificity of 80% and will identify 
>70% newborn who might eventually develop significant 
hyperbilirubinemia.
In a study by Ashish et al. [11], a critical cord bilirubin level 
≥2.50  mg/dl  has  sensitivity  of  84.1%,  specificity  of  88.5%, 
positive predictive value of 98%, and negative predictive value of 
45.1% for predicting the risk of developing pathological jaundice 
in neonates irrespective of the blood groups and risk factors. Out 
of all the above studies, only Krishnan et al. have calculated the 
cutoff value of cord blood bilirubin in predicting pathological 
jaundice among healthy term newborns with ABO setting, which 
is similar to our study.
Figure 1: Receiver operating characteristic curve of cord blood 
bilirubin in babies with ABO setting
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CONCLUSION
Our study shows that cord blood bilirubin value of ≥2.25 mg/dl 
has a sensitivity of 84% and specificity of 71.1% in predicting 
the occurrence of pathological hyperbilirubinemia in healthy term 
newborns with ABO setting.
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